1Baigrie RJ, Iamont PM, Kwiatkowski D. Systemic cytokine response after major surgery. Br J Surg, 1992; 79: 757.
2Tracey KJ, Beutler B, Lowry SF. Sheck and tissue injury by recombinant human cachectin.Science, 1986; 234: 470.
3Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor,protects mice from lethal effect of endotoxin.Science, 1985; 229: 869.
4Neilson IR. Neilson KA, Junis FJ. Failure of tumor necrosis factor to produce hypotensive shock in the absence of endotoxin, Surgery, 1989;106: 439.
5Donnelly TJ, Meade P, Jagels M. Cytokine complement and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med, 1994; 22: 768.
3Lee JW, Fang XH, Gupta N, et al. Allogeneic human mesen- chymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A, 2009, 106(38): 16357-16362.
5Dushianthan A, Grocott M, Postle AD, et al. Acute respiratory distress syndrome and acute lung injury. Postgrad Med J, 2011, 87 (1031): 612-622.
6Pierrakos C, Karanikolas M, Scolletta S, et al. Acute respiratory distress syndrome: pathophysiology and therapeutic options. J Clin Med Res, 2012, 4(1): 7-16.
7Caironi P, Cressoni M, Chiumello D, et al. Lung opening and clos- ing during ventilation of acute respiratory distress syndrome. Am J Respir Crit Care Med, 2010, 181 (6) : 578-586.
8Hart SP, Dransfield I, Rossi AG Methods, 2008, 44 (3) : 280-285.
9Briel M, Meade M, Mercat A, Phagocytosis of apoptotic cells et al. Higher vs lower positive endexpiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and eta-analysis. JAMA, 2010, 303 (9) : 865-873.
10Meng HY, Sun Y, Lu J, et aL Exogenous surfactant May improve oxygenation but not mortality in adult patients with acute lung injury/ acute respiratory distress syndrome: a meta-analysis of 9 clinical trials.J.Cardiotho~c .Vase Anesth, 2012, 26(5): 849-856.
